Serum uric acid and risk of multiple sclerosis

Journal of Neurology

Volumn 256, Issue 10, 2009, Pages 1643-1648

  Massa, Jennifer ^a   O'Reilly, E ^a   Munger, K L ^a   Delorenze, G N ^b   Ascherio, A ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DIVISION OF RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Etiology; Multiple sclerosis; Prospective; Urate; Uric acid

Indexed keywords

ADULT; ARTICLE; ASSOCIATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; URIC ACID BLOOD LEVEL;

AGE FACTORS; AGE OF ONSET; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RISK; RISK FACTORS; TIME FACTORS; URIC ACID;

EID: 70349652279     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5170-y     Document Type: Article

References (17)

1. A Ascherio KL Munger ET Lennette D Spiegelman MA Hernan MJ Olek SE Hankinson DJ Hunter 2001 Epstein-barr virus antibodies and risk of multiple sclerosis: a prospective study JAMA 286 3083 3088 10.1001/jama.286.24.3083 11754673 10.1001/jama.286.24.3083 1:CAS:528:DC%2BD38XhsFaqug%3D%3D
2. GN DeLorenze KL Munger ET Lennette N Orentreich JH Vogelman A Ascherio 2006 Epstein-barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up Arch Neurol 63 839 844 10.1001/archneur.63.6.noc50328 16606758 10.1001/archneur.63.6.noc50328 (Pubitemid 43882291)
3. GD Friedman AB Siegelaub 1980 Changes after quitting cigarette smoking Circulation 61 716 723 7357713 1:STN:280:DyaL3c7jt1ymtQ%3D%3D
4. Y Gilgun-Sherki E Melamed D Offen 2004 The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J Neurol 251 261 268 10.1007/s00415-004-0348-9 15015004 10.1007/s00415-004-0348-9 1:CAS:528:DC%2BD2cXjslGju78%3D (Pubitemid 38387142)
5. MA Hernan MJ Olek A Ascherio 1999 Geographic variation of MS incidence in two prospective studies of US women Neurology 53 1711 1718 10563617 1:STN:280:DC%2BD3c%2FisFWnsw%3D%3D
6. DC Hooper O Bagasra JC Marini A Zborek ST Ohnishi R Kean JM Champion AB Sarker L Bobroski JL Farber T Akaike H Maeda H Koprowski 1997 Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis Proc Natl Acad Sci USA 94 2528 2533 10.1073/pnas.94.6.2528 9122229 10.1073/pnas.94.6.2528 1:CAS:528:DyaK2sXhvF2ks7c%3D (Pubitemid 27136909)
7. DC Hooper S Spitsin RB Kean JM Champion GM Dickson I Chaudhry H Koprowski 1998 Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis Proc Natl Acad Sci USA 95 675 680 10.1073/pnas.95.2.675 9435251 10.1073/pnas.95.2.675 1:CAS:528: DyaK1cXmtFaisA%3D%3D (Pubitemid 28083802)
8. N Kageyama 1971 A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system Clin Chim Acta 31 421 426 10.1016/0009-8981(71)90413-X 5573684 10.1016/0009-8981(71)90413-X 1:CAS:528:DyaE3MXpsFejsQ%3D%3D
9. CM Knapp CS Constantinescu JH Tan R McLean GR Cherryman I Gottlob 2004 Serum uric acid levels in optic neuritis Mult Scler 10 278 280 10.1191/1352458504ms1042oa 15222691 10.1191/1352458504ms1042oa 1:CAS:528:DC%2BD2cXlslGltrs%3D (Pubitemid 38807454)
10. M Koch J De Keyser 2006 Uric acid in multiple sclerosis Neurol Res 28 316 319 10.1179/016164106X98215 16687059 10.1179/016164106X98215 1:CAS:528:DC%2BD28XlvVOrurw%3D (Pubitemid 43765118)
11. M Rentzos C Nikolaou M Anagnostouli A Rombos K Tsakanikas M Economou A Dimitrakopoulos M Karouli D Vassilopoulos 2006 Serum uric acid and multiple sclerosis Clin Neurol Neurosurg 108 527 531 10.1016/j.clineuro.2005.08.004 16202511 10.1016/j.clineuro.2005.08.004 1:STN:280:DC%2BD28votVWksg%3D%3D (Pubitemid 44209214)
12. KG Saag H Choi 2006 Epidemiology, risk factors, and lifestyle modifications for gout Arthritis Res Ther 8 suppl 1 S2 10.1186/ar1907 16820041 10.1186/ar1907
13. S Spitsin DC Hooper T Leist LJ Streletz T Mikheeva H Koprowskil 2001 Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease Mult Scler 7 313 319 11724447 1:CAS:528:DC%2BD3MXosVSns7g%3D
14. SV Spitsin GS Scott RB Kean T Mikheeva DC Hooper 2000 Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid Neurosci Lett 292 137 141 10.1016/S0304-3940(00)01446-4 10998568 10.1016/S0304-3940(00)01446-4 1:CAS:528:DC%2BD3cXms1WksLk%3D (Pubitemid 30682335)
15. G Toncev B Milicic S Toncev G Samardzic 2002 Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction Eur J Neurol 9 221 226 10.1046/j.1468-1331.2002.00384.x 11985629 10.1046/j.1468-1331.2002.00384.x 1:STN:280:DC%2BD38zgtFyjsA%3D%3D (Pubitemid 35013907)
16. JH Vaughan T Riise GH Rhodes MD Nguyen E Barrett-Connor H Nyland 1996 An epstein barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway J Neuroimmunol 69 95 102 10.1016/0165-5728(96)00069-0 8823380 10.1016/0165-5728(96)00069-0 1:CAS:528:DyaK28Xltlyit7s%3D
17. M Whiteman B Halliwell 1996 Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants Free Radic Res 25 275 283 10.3109/10715769609149052 8889493 10.3109/10715769609149052 1:CAS:528: DyaK28XmslOktb0%3D (Pubitemid 26356530)